| # | Drug | Count |
|---|---|---|
| 0 | PAZOPANIB HYDROCHLORIDE | 4 |
| 1 | DOXORUBICIN | 3 |
| 2 | ETOPOSIDE | 3 |
| 3 | PAZOPANIB | 3 |
| 4 | CISPLATIN | 2 |
| 5 | CYCLOPHOSPHAMIDE | 2 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 8 | SUNITINIB MALATE | 2 |
| 9 | ANTI ITCH | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARC GLASSMAN | 1 | 0.0003 |
| 1 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
| 2 | DOCUSATE CALCIUM | 1 | 0.0002 |
| 3 | DOCUSATE SODIUM SENNOSIDES | 1 | 0.0002 |
| 4 | PAZOPANIB HYDROCHLORIDE | 4 | 0.0001 |
| 5 | SUNITINIB MALATE | 2 | 0.0001 |
| 6 | SENNOSIDES 8.6 MG TABLETS | 1 | 0.0000 |
| 7 | SENNA LEAF | 1 | 0.0000 |
| 8 | TRAMETINIB | 1 | 0.0000 |
| 9 | ETOPOSIDE | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 1 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |